Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
12/2000
12/13/2000EP0724583B1 Pyridazino quinoline compounds
12/13/2000CN1276784A Cyclic amino acids and derivs. thereof useful as pharmaceutical agents
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/12/2000US6160128 Tritioacetylating reagents and processes for preparation thereof
12/12/2000US6159987 Bicyclolactam compounds, use thereof and intermediates for preparing thereof
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000CA2373937A1 Alpha v integrin receptor antagonists
12/06/2000EP1057812A1 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
12/06/2000EP1056974A1 Light polarizing materials, liquid suspensions and films thereof, and light valves incorporating same
12/06/2000EP1056724A2 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
12/06/2000EP1056455A1 Epimorphian compound and its use
12/06/2000EP1056419A1 Treatment of female sexual dysfunction
12/05/2000US6156901 Spiro[cyclopent[b]indole-piperidines]
12/05/2000US6156239 Polyhalide light-polarizing particles are made by reacting in a suitable liquid elemental molecular iodine, an inorganic halide with a rigid polycyclic compound containing two cyclic structure linked together via aromatic or heterocyclic group
11/2000
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000CA2372887A1 Heterocyclic analgesic compounds and their use
11/29/2000EP1054907A2 Method for producing aqueous polymer dispersions containing colorants
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP0702727B1 Dyes designed for high sensitivity detection of double-stranded dna
11/29/2000CN1274723A Dicyclic compound, medicine composition containing the same and use thereof
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/23/2000WO2000069862A2 Hemisynthetic method and intermediates thereof
11/23/2000WO2000069829A1 Method of inhibiting neurotrophin-receptor binding
11/23/2000WO2000069828A1 Method of inhibiting neurotrophin-receptor binding
11/23/2000WO2000069822A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069416A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives
11/23/2000WO2000034237A3 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
11/23/2000CA2373697A1 Method of inhibiting neurotrophin-receptor binding
11/23/2000CA2373416A1 Method of inhibiting neurotrophin-receptor binding
11/23/2000CA2371551A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives
11/22/2000EP1053238A1 Therapeutic compounds
11/22/2000EP1053228A1 Perylene imide monocarboxylic acids as colorants
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000CN1273974A Camptothecin derviative, its prepn. method and medicinal compsns. containing same
11/21/2000US6150414 Inhibiting a virus causing infection (such as hiv) by administering the compound 1,3,4,6-tetrahydroxy-7,16-dioxo-7,16-dihydro-dibenzo(a,o)perylene
11/21/2000US6150375 Inhibitors of both of the human 5ar isozymes; benign prostate hyperplasia, male pattern baldness, acne vulgaris, seborrhea, androgenic alopecia, hirsutism and prostate cancer; blocks the conversion of testosterone to 5-alpha-dihydrotestosterone
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/15/2000EP1052255A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics.
11/15/2000EP1051177A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
11/14/2000US6147089 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/09/2000WO2000066583A1 Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2365212A1 Substituted 3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases
11/08/2000EP1050534A1 2,3-methano-amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
11/08/2000EP0862550B1 Carboxylic acid derivatives, their preparation and their use
11/08/2000CN1272844A Benzo (5,6) cyclohepta (1,2-B) pyridine derivatives as farnesyl protein transferase inhibitors
11/08/2000CN1058265C Quinazoline derivatives and its preparing method and compositions containing the same
11/02/2000WO2000064986A1 Novel carbopyronine fluorescence dyes
11/02/2000EP1047694A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
11/02/2000DE19919119A1 Neue Carbopyronin-Fluoreszenz-Farbstoffe New carbopyronine fluorescent dyes
10/2000
10/31/2000US6140502 Heat-based process for the re-racemisation of a (-)-2-phenylmethyl-3,3-dimethyl-piperidin-4-on derivative
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6140343 Cholesteryl ester transfer protein inhibitors which are used to elevate highdensity lipoprotein-cholesterol and to lower low density lipoprotein-cholesterol and triglycerides; for treating atherosclerosis, peripheral vascular disease, obesity
10/31/2000US6140333 For treatment and/or prophylaxis of diseases include such respiratory diseases as chronic obstructive pulmonary diseases, chronic bronchitis, asthma, chronic respiratory obstruction, pulmonary fibrosis, pulmonary emphysema
10/31/2000US6140328 Heterocyclic cytotoxic agents
10/26/2000WO2000063179A1 Neurotrophin potentiators
10/26/2000WO2000063172A1 N-substituted piperidine derivatives
10/26/2000WO2000004012A9 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF
10/26/2000CA2370721A1 Neurotrophin potentiators
10/25/2000CN1271361A Tetrazole-containing rapamycin analogs with shortened half-lives
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136980 Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane
10/24/2000US6136976 Process for producing perylene-3, 4-dicarboxylic acid imides
10/19/2000WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
10/18/2000EP1044189A1 Aryl fused azapolycyclic compounds
10/17/2000US6133288 2,8-di(hydroxy)-5-((2-piperidin-1-yl)ethyoxy-1,4-phenylene)-)-5h -benzo-(e)naphtho(1,2-c)pyran; post-menopausal syndrome, osteoporosis, cardiovascular disorders; uterine fibrosis, endometriosis, and aortal smooth muscle cell proliferation
10/17/2000US6133259 Diagnosis of alzheimer's disease
10/17/2000CA2202031C Condensed indan derivatives and salts thereof
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1042356A2 Intermediates and process for the synthesis of 17-unsubstituted 16.beta.-aryloxy 4-azasteroids
10/11/2000EP1042295A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
10/11/2000EP1042294A1 Heterocyclic cytotoxic agents
10/11/2000EP1042287A1 Indole derivatives as inhibitors of factor xa
10/11/2000CN1269790A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments
10/11/2000CN1057297C Waterless crystallization of quinolone derivative and crystallization method of its 3/2 hydrate
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/10/2000US6130228 Alzheimers
10/10/2000US6130227 7-Substituted camptothecin derivatives and methods for inhibiting the growth of tumor cells therewith
10/05/2000WO2000058406A1 4,7-dichlororhodamine dyes useful as molecular probes
10/04/2000EP1041071A1 Methods for the preparation of coumarine derivatives
10/04/2000EP1041066A1 Steroid receptor modulator compounds and methods
10/04/2000EP1040097A1 Potassium channel openers
10/04/2000EP0708773B1 Fused cycloalkylimidazopyridines
10/03/2000US6127550 By reacting a 2-amino-2-substituted ethyl alcohol having position 2 chirality(2-*) with a halide in the presence of a base to form a 2-substituted, 2-* aziridine, reacting with a lithium compound to form a salt, treating with strong acid
10/03/2000US6127383 Treatment of arteriosclerosis
10/03/2000US6127378 Phenanthridines substituted in the 6 position
10/03/2000US6126870 Chemiluminescent labeling compounds
09/2000
09/27/2000EP1037892A1 Piperidine derivatives
09/27/2000CN1268136A Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
09/26/2000US6124459 Process for preparing pharmaceutically useful norbenzomorphane derivative
09/26/2000US6124458 Substituted quaterrylene tetracarboxylic acid diimides
09/26/2000US6124312 Heterocyclic compounds
09/26/2000US6124295 Inhibit growth of abnormal cells, such as tumor cells
09/21/2000WO2000055118A1 Nuclear receptor arylating compounds
09/21/2000WO2000032577A3 Substituted benzo[de]isoquinoline-1,3-diones
09/20/2000EP1036058A1 Adamantane derivatives
09/20/2000CN1267300A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl protein transferase
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 110